MENG LV 吕萌

Associate Professor and TCT Physician of Peking University @pku1898 Institute of Hematology

[MENG LV 吕萌 @Dr_LvMeng]

提供完整应聘资料，发送至邮箱：[email protected],邮件主题为“姓名+xx科预聘-长聘制应聘”：1、个人简历。应该包括个人基本信息、学习和工作经历、主要学术成就（代表性研究论文、项目、专利转化及奖励情况等）2、近5年主持课题批件。3、所在领域代表性研究成果（SCl论著全文）

[MENG LV 吕萌 @Dr_LvMeng]

欢迎海外游学博后以预聘-长聘新体制加入北大血液团队：北京大学人民医院，北京大学血液病研究为国家血液系统疾病临床医学研究中心、国家自然基金委创新研究群体、血液肿瘤细胞和基因治疗北京市重点实验室。

[MENG LV 吕萌 @Dr_LvMeng]

Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes https://t.co/mi1V9Iyy2J

[MENG LV 吕萌 @Dr_LvMeng]

@drliuhao 浩子新春快乐！ 对Lunar New Year 和Chinese New Year 之争，啥看法😛

[MENG LV 吕萌 @Dr_LvMeng]

Happy Lunar New Year

[MENG LV 吕萌 @Dr_LvMeng]

https://t.co/6uT0xhHD7X

[MENG LV 吕萌 @Dr_LvMeng]

"I'm Groot" https://t.co/xHVWWnf9iF

[iMeta @iMetaScience]

Applying multi‐omics toward tumor microbiome research, reviewed by @QZ_ChemSynBiol
#Bioinformatics #microbiome #metagenomics #multiomics #Cancer #tumor #MedTwitter
@wileymicrobio @WileyBiomedical @WileyHealth
https://t.co/CUoyVpArsU

[MENG LV 吕萌 @Dr_LvMeng]

@BloodJournal Errors in table3 for 4 HRs which should be above 1: Age at diagnosis, Lower-risk patients(Td AML,Td allo-HCT (without AML): 0-2y, high risk (Td AML) https://t.co/ifamCHI9UP

[Benlazar S M A @smbenlazar]

Phase I/II Trial of Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed/Refractory #AML #ASH22

[Steven Ge @StevenXGe]

Happy holidays! Introducing https://t.co/Ub3wgs1KVz, an AI-powered app that lets you chat with your data in English! RTutor uses Davinci (#ChatGPT’s sibling) to turn requests into R code, which is executed & results are shown instantly, available as a HTML report in seconds. 1/8

[van den Brink Lab @vandenBrinkLab]

Quick recap of the VDB Lab + friends at #ASH22 📣 #ASHkudos to our amazing presenters! See you all next year!

[MENG LV 吕萌 @Dr_LvMeng]

Thanks @ASTCT for this valuable opportunity to present our data in Tandem Meeting 2023 #Tandem23

[van den Brink Lab @vandenBrinkLab]

Today at #ASH22 ➡️ Microbial bile acid metabolism shapes effector T cell response during inflammation in mouse and human. @DrSarahLindner @Orianamilt 🙌

[iMeta @iMetaScience]

ggClusterNet: An R package for microbiome network analysis and modularity‐based multiple network layouts, developed by @TaoWen82417266 @YongXinLiu7.
#bioinformatics #microbiome #metagenomics #network #RStats
@wileymicrobio @wileyinresearch https://t.co/OJtP6QHYAQ

[van den Brink Lab @vandenBrinkLab]

Today at #ASH22 ➡️ Inflammatory #biomarker clusters are predictive of response and #toxicity in large B-cell #lymphoma treated with CD19 #CART cell therapy. @SSRaj017 👏

[MENG LV 吕萌 @Dr_LvMeng]

ASH Education Book2022| American Society of Hematology https://t.co/161W6vIMoX

[MENG LV 吕萌 @Dr_LvMeng]

Congratulation！ One of my essential tools

[Daniel Sjoberg @statistishdan]

Please to announce the latest release of the {gtsummary}📦!

My favorite new feature is that header rows in flextable output now recognize markdown syntax for bold/italic😍🤓

https://t.co/DkXk3jD2RS
#rstats #datascience #gtsummary

[MENG LV 吕萌 @Dr_LvMeng]

Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation https://t.co/wYKXjxvcFe

[Marcel van den Brink @DrMvandenBrink]

Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease https://t.co/V9Y6x3LwG3